Will THTX backtrack from these statements??Although TXTH has been very tight-lipped (wow, that's an understatement), there are two statements directly from Paul that he has not yet retracted or modified (from what I recall):
- NASH trial to begin in 3rd quarter
- 20-25% Q/Q growth of revenues from Egrifta & Trogarzo.
We'll see if he comments on or retracts either of these on Thursday.
-LT